NCT02052362View on ClinicalTrials.gov

Bioavailability of ABT-450 and ABT-267 With Ritonavir

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Absolute Bioavailability

Interventions

DRUG

ABT-450/r/ABT-267

ABT-450, ABT-267 and ritonavir

Trial Locations (1)

NG11 6JS

Site Reference ID/Investigator# 118615, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY